2013 annual financial data

Viridian Therapeutics 2013 Net margin

Direct answer

Net margin was -50.03%.

Operating income was -196,213 USD and net income was -2.16M USD.
Operating cash flow was -1.17M USD.

Get free Viridian Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4.32M USD
Operating income
-196,213 USD
Net income
-2.16M USD
Operating cash flow
-1.17M USD